CPR APPLICATIONS FOUNDATION · CHAPTER 10 · TREATMENT
Treatment Foundations of Hematology
Organize the chapter before drilling into individual CPR concepts.
Supplemental foundation map: this page orients the detailed CPR Applications for Chapter 10. It is not part of the canonical CPR object inventory.
Move through Chapter 10
Normal Foundations
Abnormal Foundations
Treatment Foundations · You are here
10.29 · SOURCE CPR FOUNDATION
Concept
Hematology pharmacology targets primary hemostasis, secondary hemostasis, missing substrates, and disease-modifying mechanisms. Antiplatelets impair platelet activation or aggregation. Anticoagulants impair coagulation-factor activity or synthesis, while replacement therapies restore missing inputs for RBC production.
Pattern
Step 1 treatment questions usually ask what step is targeted and what complication follows. Platelet-driven arterial thrombosis favors antiplatelet logic. Venous thromboembolism and atrial fibrillation stroke prevention favor anticoagulation logic, while anemia treatment depends on the missing substrate or upstream mechanism.
Rule
- Identify the target step: decide platelets, factors, missing substrate, or disease-modifying pathway.
- Ask how fast the therapy works: immediate enzyme inhibition differs from delayed factor synthesis effects.
- Predict the mechanism-linked danger: bleeding, HIT, marrow effects, or toxicity follows from the treatment target.
Applications
- Atherosclerotic platelet-rich arterial thrombosis → antiplatelet logic; cardioembolic arterial events may instead require anticoagulation according to source and risk
- Venous thrombosis → anticoagulant logic
- Microcytic iron deficiency → iron replacement
- Sickle cell disease → distinguish acute vaso-occlusive pain management from disease-modifying prevention such as hydroxyurea or other indication-specific therapies
- Tip: Hematology drug questions are easiest when solved by asking whether the target is platelets, factors, or missing substrate.
CPR APPLICATIONS · ACTIVE REASONING
Match hematologic therapy to the defective step
Choose a response before checking its mechanism. Every worked solution is also available through the expandable explanation if scripts are blocked. Responses are not saved.
Reveal worked reasoning and transfer
Best answer: Platelet thromboxane A2-dependent activation. Aspirin inhibits platelet COX-1, reducing thromboxane A2 formation and platelet activation.
Counterfactual: Why does anticoagulation have a different central target than aspirin?
Reveal worked reasoning and transfer
Best answer: Coagulation-factor Xa activity. Xa inhibition reduces thrombin generation, targeting secondary hemostasis.
Counterfactual: What clinically important harm follows from anticoagulant activity?
Reveal worked reasoning and transfer
Best answer: Supply substrate for hemoglobin synthesis. Iron replacement supports erythropoiesis when deficient; clinical response depends on absorption and continued losses.
Counterfactual: Why should treatment also address the source of iron deficiency?
Change the mechanism
Scenario explanations without scripts
- Platelet-rich atherosclerotic thrombosis: Antiplatelet therapy addresses platelet activation or aggregation and carries bleeding risk.
- Venous thromboembolism: Anticoagulation targets coagulation activity; drug choice depends on patient factors.
- Iron deficiency: Replace the depleted substrate and evaluate the cause of deficiency.
Explain it back: Describe which observation would change the conclusion and why. These are unscored educational exercises, not medical treatment instructions.
How to use this foundation map
- Identify the organizing mechanism.
- Recognize the pattern.
- Restate the rule without looking.
- Test transfer with the applications and question practice.
Pair CPR with the 5P Approach™ when solving cases and questions.